Cormorant Asset Management, LP sold $1.7M of CRBP stock
By AlphaYouPublished Form 4
Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Chen Bihua
Reporting filer
Cormorant Asset Management, LP reported selling 425,000 shares of Corbus Pharmaceuticals Holdings, Inc. for about $1.7M ($4.10 a share on average). Form 4 filed Nov 2, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Chen Bihua | 2026-10-29 | S | Sale | 425000 | 4.1006 | 1,919,971 | 4 days | Filed terms
|
Common Stock
- Owner
- Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Chen Bihua
- Date
- 2026-10-29
- Code
- S
- Action
- Sale
- Quantity
- 425000
- Price
- 4.1006
- Following holdings
- 1,919,971
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-29
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 425000
- transaction Price Per Share: 4.1006
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 1919971
- direct Or Indirect Ownership: I
- nature Of Ownership: See Footnotes
- id: F2
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Cormorant Asset Management, LP: Other reporting owner.
- Cormorant Global Healthcare Master Fund, LP: Other reporting owner.
- Chen Bihua: Other reporting owner.
- F1: The reported price represents the weighted average sale price of Common Stock (the "shares") sold in a series of open market transactions on the transaction date at prices ranging from $4.10 to $4.27 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were sold by the Master Fund.
- F2: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as the general partner of the Master Fund. Bihua Chen serves as the managing member of Cormorant, GP LLC and the Master Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
Original sources
Prepared automatically from public filing data. Report a correction.